Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nausea And Vomiting Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Serotonin Receptor Antagonist
1.2.3 Neurokinin NK1 Receptor Antagonist
1.2.4 Others
1.3 Market by Application
1.3.1 Global Nausea And Vomiting Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 CINV
1.3.3 PONV
1.3.4 Motion Sickness
1.3.5 Pregnancy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nausea And Vomiting Treatment Market Perspective (2019-2030)
2.2 Nausea And Vomiting Treatment Growth Trends by Region
2.2.1 Global Nausea And Vomiting Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nausea And Vomiting Treatment Historic Market Size by Region (2019-2024)
2.2.3 Nausea And Vomiting Treatment Forecasted Market Size by Region (2025-2030)
2.3 Nausea And Vomiting Treatment Market Dynamics
2.3.1 Nausea And Vomiting Treatment Industry Trends
2.3.2 Nausea And Vomiting Treatment Market Drivers
2.3.3 Nausea And Vomiting Treatment Market Challenges
2.3.4 Nausea And Vomiting Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nausea And Vomiting Treatment Players by Revenue
3.1.1 Global Top Nausea And Vomiting Treatment Players by Revenue (2019-2024)
3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Nausea And Vomiting Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nausea And Vomiting Treatment Revenue
3.4 Global Nausea And Vomiting Treatment Market Concentration Ratio
3.4.1 Global Nausea And Vomiting Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nausea And Vomiting Treatment Revenue in 2023
3.5 Nausea And Vomiting Treatment Key Players Head office and Area Served
3.6 Key Players Nausea And Vomiting Treatment Product Solution and Service
3.7 Date of Enter into Nausea And Vomiting Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nausea And Vomiting Treatment Breakdown Data by Type
4.1 Global Nausea And Vomiting Treatment Historic Market Size by Type (2019-2024)
4.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2025-2030)
5 Nausea And Vomiting Treatment Breakdown Data by Application
5.1 Global Nausea And Vomiting Treatment Historic Market Size by Application (2019-2024)
5.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nausea And Vomiting Treatment Market Size (2019-2030)
6.2 North America Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nausea And Vomiting Treatment Market Size by Country (2019-2024)
6.4 North America Nausea And Vomiting Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nausea And Vomiting Treatment Market Size (2019-2030)
7.2 Europe Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nausea And Vomiting Treatment Market Size by Country (2019-2024)
7.4 Europe Nausea And Vomiting Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nausea And Vomiting Treatment Market Size (2019-2030)
8.2 Asia-Pacific Nausea And Vomiting Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nausea And Vomiting Treatment Market Size (2019-2030)
9.2 Latin America Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nausea And Vomiting Treatment Market Size by Country (2019-2024)
9.4 Latin America Nausea And Vomiting Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nausea And Vomiting Treatment Market Size (2019-2030)
10.2 Middle East & Africa Nausea And Vomiting Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & Co. Inc.
11.1.1 Merck & Co. Inc. Company Detail
11.1.2 Merck & Co. Inc. Business Overview
11.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Introduction
11.1.4 Merck & Co. Inc. Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.1.5 Merck & Co. Inc. Recent Development
11.2 Helsinn Group
11.2.1 Helsinn Group Company Detail
11.2.2 Helsinn Group Business Overview
11.2.3 Helsinn Group Nausea And Vomiting Treatment Introduction
11.2.4 Helsinn Group Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.2.5 Helsinn Group Recent Development
11.3 Unimed Pharmaceuticals (AbbVie Inc.)
11.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Detail
11.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
11.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Introduction
11.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Development
11.4 Kyowa Kirin
11.4.1 Kyowa Kirin Company Detail
11.4.2 Kyowa Kirin Business Overview
11.4.3 Kyowa Kirin Nausea And Vomiting Treatment Introduction
11.4.4 Kyowa Kirin Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.4.5 Kyowa Kirin Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Nausea And Vomiting Treatment Introduction
11.5.4 Sanofi Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 Qilu Pharma
11.6.1 Qilu Pharma Company Detail
11.6.2 Qilu Pharma Business Overview
11.6.3 Qilu Pharma Nausea And Vomiting Treatment Introduction
11.6.4 Qilu Pharma Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.6.5 Qilu Pharma Recent Development
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Introduction
11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.8 Taiji group
11.8.1 Taiji group Company Detail
11.8.2 Taiji group Business Overview
11.8.3 Taiji group Nausea And Vomiting Treatment Introduction
11.8.4 Taiji group Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.8.5 Taiji group Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Nausea And Vomiting Treatment Introduction
11.9.4 Novartis Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Heron Therapeutics
11.10.1 Heron Therapeutics Company Detail
11.10.2 Heron Therapeutics Business Overview
11.10.3 Heron Therapeutics Nausea And Vomiting Treatment Introduction
11.10.4 Heron Therapeutics Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.10.5 Heron Therapeutics Recent Development
11.11 Pharmanovia
11.11.1 Pharmanovia Company Detail
11.11.2 Pharmanovia Business Overview
11.11.3 Pharmanovia Nausea And Vomiting Treatment Introduction
11.11.4 Pharmanovia Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.11.5 Pharmanovia Recent Development
11.12 Mylan
11.12.1 Mylan Company Detail
11.12.2 Mylan Business Overview
11.12.3 Mylan Nausea And Vomiting Treatment Introduction
11.12.4 Mylan Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.12.5 Mylan Recent Development
11.13 Duchesnay
11.13.1 Duchesnay Company Detail
11.13.2 Duchesnay Business Overview
11.13.3 Duchesnay Nausea And Vomiting Treatment Introduction
11.13.4 Duchesnay Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.13.5 Duchesnay Recent Development
11.14 GSK
11.14.1 GSK Company Detail
11.14.2 GSK Business Overview
11.14.3 GSK Nausea And Vomiting Treatment Introduction
11.14.4 GSK Revenue in Nausea And Vomiting Treatment Business (2019-2024)
11.14.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details